Bone News and Research

RSS

New Mayo Clinic study shows impact of long-term use of proton pump inhibitors

Before reaching for that daily antacid, you might consider what it's doing to the trillions of bugs living in your gut. A new Mayo Clinic study in the open access journal Microbiome shows that people who regularly take proton pump inhibitors (PPIs) have less diversity among their gut bacteria, putting them at increased risk for infections like clostridium difficile and pneumonia, in addition to vitamin deficiencies and bone fractures.

25 Nov 2014

ContextVision to launch new groundbreaking product for 3D ultrasound at RSNA 2014

At the upcoming 100th Scientific Assembly and Annual Meeting of RSNA, ContextVision, will launch a new groundbreaking product range for 3D ultrasound. The new second generation of 3D volume processing and the photo-like 3D rendering software provides new features that brings 3D imaging to a higher level. The products offer a higher diagnostic value and support further use of 3D ultrasound.

24 Nov 2014

Researchers make significant breakthrough for sufferers of bone disease

Researchers in bone tissue regeneration believe they have made a significant breakthrough for sufferers of bone trauma, disease or defects such as osteoporosis.

24 Nov 2014

Two medical research bodies announce new research centre to tackle musculoskeletal disorders

A major new research centre to tackle the impact of musculoskeletal disorders on people's ability to work has been announced by two leading medical research bodies.

24 Nov 2014

NC State researchers develop technique that allows ultrasound to penetrate bone or metal

Researchers from North Carolina State University have developed a technique that allows ultrasound to penetrate bone or metal, using customized structures that offset the distortion usually caused by these so-called "aberrating layers."

23 Nov 2014

Endocrine Society issues Clinical Practice Guideline on rare bone condition

The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of Paget's disease of the bone, a condition where one or more bones in the body become oversized and weak.

23 Nov 2014

Clementia gets Orphan Medicinal Product Designation from EMA for palovarotene

Clementia Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has granted Orphan Medicinal Product Designation for palovarotene, the company's lead product candidate, for the treatment of fibrodysplasia ossificans progressiva (FOP).

21 Nov 2014

Gene therapy transforms life for men with severe form of hemophilia B

Gene therapy developed at St. Jude Children's Research Hospital, University College London and the Royal Free Hospital has transformed life for men with a severe form of hemophilia B by providing a safe, reliable source of the blood clotting protein Factor IX that has allowed some to adopt a more active lifestyle, researchers reported.

19 Nov 2014

BerGenBio's BGB324 gets orphan-drug designation from FDA for AML treatment

BerGenBio AS, an oncology biopharmaceutical company, today announces that the US Food and Drug Administration has granted orphan-drug designation for BGB324 for treatment of acute myeloid leukaemia (AML).

19 Nov 2014

Moffitt announces development of innovative investigational biologic agent for MDS

In a major step to treat patients living with Myelodysplastic Syndromes (MDS), a group of diseases that affect the bone marrow and blood, Moffitt Cancer Center today announced the development of an innovative investigational biologic agent that could improve patient response and outcomes for MDS and other diseases.

18 Nov 2014

$Study finds link between body weight change and hip fracture risk among Singapore Chinese$

Study finds link between body weight change and hip fracture risk among Singapore Chinese

While a low body mass index (BMI) of less than 20 kg/m2 has been shown to be an independent risk factor for hip fractures, far less is known about the relationship of body weight changes on hip fracture risk.

17 Nov 2014

Plymouth researchers receive 2014 Oral and Dental Research Trust-GSK Research Award

Researchers from Plymouth University Peninsula Schools of Medicine and Dentistry have received one of the prestigious 2014 Oral and Dental Research Trust-GSK Research Awards from the British Society of Oral and Dental Research, for a research project which seeks to re-programme the immune system to stop bone destruction and tooth loss in severe gum disease.

16 Nov 2014

Chaetocin synergistic with TKIs against CML cells

Chaetocin, a mycotoxin that increases oxidative stress, can complement the activity of tyrosine kinase inhibitors in chronic myeloid leukaemia by overcoming innate resistance mediated by secreted bone marrow stromal cytokines and growth factors, researchers report.

14 Nov 2014

Bone News and Research

New Mayo Clinic study shows impact of long-term use of proton pump inhibitors

ContextVision to launch new groundbreaking product for 3D ultrasound at RSNA 2014

Researchers make significant breakthrough for sufferers of bone disease

Two medical research bodies announce new research centre to tackle musculoskeletal disorders

NC State researchers develop technique that allows ultrasound to penetrate bone or metal

Endocrine Society issues Clinical Practice Guideline on rare bone condition

Clementia gets Orphan Medicinal Product Designation from EMA for palovarotene

Gene therapy transforms life for men with severe form of hemophilia B

BerGenBio's BGB324 gets orphan-drug designation from FDA for AML treatment

Moffitt announces development of innovative investigational biologic agent for MDS

Study finds link between body weight change and hip fracture risk among Singapore Chinese

Plymouth researchers receive 2014 Oral and Dental Research Trust-GSK Research Award

Chaetocin synergistic with TKIs against CML cells

Exposure to tobacco smoke, roadway air pollution can contribute to obesity

New anti-cancer drug may protect normal cells against radiation

Load bearing, biodegradable implants can reduce the number of second surgeries

Researchers find key mechanism that could lead to new effective treatments for leukemias

DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

Scientists use Rapid Heme Panel test to identify right treatment for leukemia, other blood cancers

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News